Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice
$377,448Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Characterization of the interaction between inflammation and cancer progression
$377,448Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
NFAT activation in kGPCR tumorigenesis
$377,438Pinghui Feng · University Of Southern California · R01 · FY2017 · CA
Targeting Cancer through Suppressing Stress Induction of GRP78/BiP
$377,438Amy S Lee · University Of Southern California · R01 · FY2020 · CA
NFAT activation in kGPCR tumorigenesis
$377,438Pinghui Feng · University Of Southern California · R01 · FY2020 · CA
Targeting Cancer through Suppressing Stress Induction of GRP78/BiP
$377,438Amy S Lee · University Of Southern California · R01 · FY2021 · CA
NFAT activation in kGPCR tumorigenesis
$377,438Pinghui Feng · University Of Southern California · R01 · FY2021 · CA
Research Project 2: Neuroblastoma
$377,436Dipanjan Chowdhury · Dana-Farber Cancer Inst · U54 · FY2023 · CA
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$377,428David G Denardo · Washington University · P50 · FY2025 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$377,401Pepper J Schedin · Oregon Health & Science University · R01 · FY2023 · CA
Project 2: Dual Targeting of B7-H3 in mCRPC
$377,386Kenneth J. Pienta · Johns Hopkins University · P50 · FY2025 · CA
Synstatin Therapy for Multiple Myeloma
$377,380Alan C Rapraeger · University Of Wisconsin-Madison · R01 · FY2014 · CA
Project 2: Profiling Gene Expression and Mechanophenotype in Circulating Tumor Cells Ex Vivo
$377,375Ian Y Wong · Brown University · P20 · FY2021 · GM
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$377,327Fumito Ito · University Of Southern California · R01 · FY2024 · CA
USP18 in Cancer Development
$377,288Dong-Er Zhang · University Of California, San Diego · R01 · FY2020 · CA
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$377,239Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2022 · NS
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$377,239Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2023 · NS
Cellular Interactions with the Extracellular Matrix of the Tumor Microenvironment
$377,222Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2010 · CA
Discovery of Gene Expression Signatures in Cancer Stroma
$377,216Robert B West · Stanford University · R01 · FY2011 · CA
Project 1: Combined Suppression of MYC as therapy for CRPC: the COSMYC trial
$377,111Samuel R Denmeade · Johns Hopkins University · P50 · FY2025 · CA
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$377,088Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2024 · NS
Tumor and Stromal Metalloproteinases in Breast Cancer
$377,084Lynn M Matrisian · Vanderbilt University · R01 · FY2010 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$377,055Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Dual orthogonal fluorescent protease sensors for image guided surgery
$377,028Matthew S Bogyo · Stanford University · R01 · FY2020 · EB
Innate and Adaptive Anti-Myeloma Immunity
$377,027Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2012 · CA